Article Versions Notes

Scutigliani EM, Liang Y, IJff M, Rodermond H, Mei X, Korver MP, Orie VS, Hoebe RA, Picavet DI, Oei A, et al. Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments. Cancers. 2022; 14(21):5250. https://doi.org/10.3390/cancers14215250

Scutigliani, Enzo M., Yongxin Liang, Marloes IJff, Hans Rodermond, Xionge Mei, Miriam P. Korver, Vaneesha S. Orie, Ron A. Hoebe, Daisy I. Picavet, Arlene Oei, and et al. 2022. "Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments" Cancers 14, no. 21: 5250. https://doi.org/10.3390/cancers14215250

Scutigliani, E. M., Liang, Y., IJff, M., Rodermond, H., Mei, X., Korver, M. P., Orie, V. S., Hoebe, R. A., Picavet, D. I., Oei, A., Kanaar, R., & Krawczyk, P. M. (2022). Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments. Cancers, 14(21), 5250. https://doi.org/10.3390/cancers14215250